If you’re considering a subscription, or even just a trial – it may be helpful to see how many of our members work with the signals. This brief video will cover: Patterns to watch for Evaluating the event Trade set-ups to consider
The November 2017 scorecard for the signals generated from Sonal can be downloaded here. The results are summarized in this table: Scorecard Total Repurchases M&A Guidance Contracts Clinical Trials Correct – Prev Close to Next Close 65% 65% 89% 63% 57% 67% Correct – Prev Close to Next Session Peak 87% 86% 89% 83% 95% […]
KLX, Inc. announced its third-quarter earnings on December 6. The company reported operating earnings of $60.5 million, which was an increase of 56.7% over the same quarter last year. KLX increased its estimated adjusted net earnings per share by $0.10 to $3.10 per diluted share. KLX is a leading distributor and service provider of fasteners […]
On November 27, Catalyst Pharmaceutical, Inc. (CPRX) announced positive phase 3 clinical trial results from its drug Firdapse. This was the second phase 3 trial of Firdapse, which shows statistically significant improvement for symptomatic treatment of Lambert-Eaton Myasthenic Syndrome (LEMS). LEMS is a rare autoimmune disorder in which nerves have trouble sending to muscle cells, […]
On December 1, Lannett Company, Inc. (LCI) announced FDA acceptance of its 505(b)(2) New Drug Application (NDA) for Cocaine Hydrochloride (HCl) Topical Solution. The drug is a proprietary local topical anesthetic with the proposed name Numbrino. The submission is supported by two successful Phase 3 clinical trials. Sonal detected the event and sent an […]
Let us send you a summary of the signals Sonal generates EVERY WEEK… and you can decide if you’re missing anything.